How Does Autologous Fat Grafting for Apple Cheeks Work?

Autologous fat grafting to the malar region—commonly referred to as “apple cheek” augmentation—is a minimally invasive cosmetic procedure designed to restore volume, enhance facial contour, and counteract age-related fat atrophy in the midface. In this technique, adipose tissue is harvested via gentle liposuction—typically from the abdomen, flanks, or thighs—then processed to isolate viable adipocytes and stromal vascular fraction (SVF) before being micro-injected into the deep malar fat pad using fine-gauge cannulas.

The procedure leverages the patient’s own tissue, eliminating risks associated with foreign-body reactions or immunogenicity. However, successful outcomes depend critically on meticulous surgical technique: over-harvesting or aggressive centrifugation can compromise adipocyte viability, while improper injection depth—either too superficial (risking visible nodularity or skin discoloration) or too deep (potentially affecting infraorbital neurovascular structures)—may lead to suboptimal aesthetic results or complications.

On average, 30–50% of transplanted fat undergoes resorption within the first three to six months postoperatively. For this reason, many surgeons employ strategic overcorrection—typically 20–30% above the target volume—to account for expected graft loss. Long-term stability relies on successful neovascularization of the grafted tissue; once integrated, surviving adipocytes behave physiologically like native fat, responding to weight fluctuations and aging similarly.

Candidates are generally healthy adults with mild-to-moderate midfacial volume deficiency, adequate donor-site fat, and realistic expectations. Contraindications include uncontrolled systemic disease, active infection, significant coagulopathy, or unrealistic aesthetic goals. As with any surgical intervention, patients must be counseled on potential risks—including contour irregularities, asymmetry, fat necrosis, cyst formation, and, rarely, vascular compromise leading to skin or retinal injury if injected inadvertently into arterial branches.

Recovery is typically brief: most patients resume non-strenuous activities within 3–5 days, though swelling and mild ecchymosis may persist for 1–2 weeks. Final aesthetic assessment should be deferred until at least three months post-procedure, allowing time for full graft maturation and resolution of edema.